IVIG for Autoimmune Mucocutaneous Blistering Diseases
Research has shown that IVIG is a promising treatment option for patients with autoimmune mucocutaneous blistering diseases (AMBDs), a group of conditions that cause painful blisters, sores, and sometimes scarring on the skin or mucous membranes.
